Tumor Ablation Technologies

Tumor Ablation Technologies

Global Tumor Ablation Technologies Market to Reach $2.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Tumor Ablation Technologies estimated at US$967.3 Million in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 13.2% over the analysis period 2020-2027. Radiofrequency Ablation, one of the segments analyzed in the report, is projected to record a 13.7% CAGR and reach US$875.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Microwave Ablation segment is readjusted to a revised 14.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $279.8 Million, While China is Forecast to Grow at 12.4% CAGR

The Tumor Ablation Technologies market in the U.S. is estimated at US$279.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$396.3 Million by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.9% and 11.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.

Cryoablation Segment to Record 12.9% CAGR

In the global Cryoablation segment, USA, Canada, Japan, China and Europe will drive the 12.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$170.7 Million in the year 2020 will reach a projected size of US$396.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 46 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG International Ltd.
  • EDAP TMS SA
  • Galil Medical Ltd.
  • HealthTronics, Inc.
  • Medtronic PLC
  • Mermaid Medical A/S
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tumor Ablation Technologies – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Radiofrequency Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Cryoablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for IRE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for IRE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for IRE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Other Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Other Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Other Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Liung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Liung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Liung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 34: World Tumor Ablation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 36: USA Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 37: USA 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 38: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 39: USA Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 40: USA 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
CANADA
TABLE 41: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 42: Canada Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 43: Canada 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 44: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 45: Canada Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 46: Canada 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 48: Japan Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 49: Japan 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 50: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 51: Japan Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 52: Japan 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
CHINA
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 54: China Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 55: China 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 56: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 57: China Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 58: China 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 59: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 60: Europe Historic Review for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 61: Europe 15-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 62: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 63: Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 64: Europe 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 65: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 66: Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 67: Europe 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
FRANCE
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 68: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 69: France Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 70: France 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 71: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 72: France Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 73: France 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 74: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 75: Germany Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 76: Germany 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 77: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 78: Germany Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 79: Germany 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
ITALY
TABLE 80: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 81: Italy Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 82: Italy 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 83: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 84: Italy Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 85: Italy 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 86: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 87: UK Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 88: UK 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 89: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 90: UK Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 91: UK 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 93: Rest of Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 96: Rest of Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 97: Rest of Europe 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 104: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 105: Rest of World Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 106: Rest of World 15-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, IRE and Other Ablation Technologies for the Years 2012, 2021 & 2027
TABLE 107: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 108: Rest of World Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 109: Rest of World 15-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Liung Cancer, Prostate Cancer, Breast Cancer and Other Applications for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings